BRANCACCIO, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 1.983
NA - Nord America 1.075
SA - Sud America 546
EU - Europa 301
AF - Africa 33
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.941
Nazione #
US - Stati Uniti d'America 1.016
SG - Singapore 856
BR - Brasile 435
CN - Cina 373
HK - Hong Kong 254
VN - Vietnam 233
KR - Corea 86
IT - Italia 67
AR - Argentina 48
GB - Regno Unito 47
DE - Germania 33
NL - Olanda 32
IN - India 28
FR - Francia 27
CA - Canada 26
BD - Bangladesh 24
EC - Ecuador 22
JP - Giappone 21
FI - Finlandia 20
ID - Indonesia 19
MX - Messico 17
IL - Israele 13
ZA - Sudafrica 13
CO - Colombia 12
RU - Federazione Russa 11
TR - Turchia 11
IQ - Iraq 9
LT - Lituania 8
PK - Pakistan 8
SA - Arabia Saudita 8
AT - Austria 7
BE - Belgio 7
UY - Uruguay 7
VE - Venezuela 7
AZ - Azerbaigian 6
CL - Cile 6
PY - Paraguay 6
JO - Giordania 5
PL - Polonia 5
UA - Ucraina 5
UZ - Uzbekistan 5
AL - Albania 4
EG - Egitto 4
ES - Italia 4
OM - Oman 4
PA - Panama 4
SE - Svezia 4
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
JM - Giamaica 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 3.941
Città #
Santa Clara 605
Singapore 528
Hong Kong 254
Hefei 202
Seoul 86
Beijing 81
Ho Chi Minh City 67
Dallas 50
Hanoi 50
Ashburn 40
Los Angeles 37
Milan 31
São Paulo 30
San Jose 29
Rome 20
Rio de Janeiro 19
New York 15
Buffalo 14
Frankfurt am Main 13
London 11
Minamishinagawa 11
Toronto 11
Brasília 10
Bristol 10
Haiphong 10
Helsinki 10
Belo Horizonte 9
Bengaluru 9
Curitiba 9
Dhaka 9
Lappeenranta 9
Porto Alegre 9
Tokyo 9
Da Nang 8
Nuremberg 8
Brooklyn 7
Brussels 7
Campinas 7
Houston 7
Hải Dương 7
Johannesburg 7
Lấp Vò 7
Quito 7
Buenos Aires 6
Düsseldorf 6
Montevideo 6
Riyadh 6
Amman 5
Aracaju 5
Baku 5
Biên Hòa 5
Bình Dương Province 5
Can Tho 5
Guayaquil 5
Lahore 5
Marília 5
Orem 5
Portsmouth 5
Carapicuíba 4
Denver 4
Goiânia 4
Recife 4
Tashkent 4
Vienna 4
Vitória da Conquista 4
Anápolis 3
Athens 3
Baghdad 3
Blumenau 3
Bogotá 3
Boston 3
Bình Dương 3
Chicago 3
Concordia 3
Ha Long 3
Hortolândia 3
Jakarta 3
Joinville 3
Lauterbourg 3
Macapá 3
Macaé 3
Maceió 3
Manchester 3
Montreal 3
Nairobi 3
Ottawa 3
Panama City 3
Pelotas 3
Phoenix 3
Quận Hai 3
Roubaix 3
Salvador 3
Santiago de Cali 3
Santo André 3
Seeb 3
Stockholm 3
São Gonçalo 3
São José do Rio Preto 3
Taboão da Serra 3
Thái Nguyên 3
Totale 2.591
Nome #
Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks 80
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line 78
Analysis of the enzymatic activity of MMP-9 and MMP-2 on the recombinant domains of dystroglycan 73
O mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function 72
The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization 70
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin 69
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core portein in some, but not all, dystroglycanopathy patients 64
Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology 63
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 62
The molecular basis and biologic significance of the beta-dystroglycan-emerin interaction 54
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. 52
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1 51
The consequence of ATP synthase dimer angle on mitochondrial morphology studied by cryo-electron tomography 46
Molecular and structural basis of dystroglycanopathies 45
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 44
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 44
Alpha-dystroglycan is a potential target of matrix metalloproteinase MMP-2 43
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 43
Determination of Agrin and Related Proteins Levels as a Function of Age in Human Hearts 42
Agrin-Mediated Cardiac Regeneration: Some Open Questions 42
The α-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses 41
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 40
Loss of dystroglycan drives cellular senescence via defective mitosis-mediated genomic instability 40
High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of alpha-dystroglycan 40
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 39
Identification and Modeling of a GT-A Fold in the ?-Dystroglycan Glycosylating Enzyme LARGE1 39
Perturbation of the alpha/beta-dystroglycan interaction: consequences for skeletal muscle stability 38
Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex 37
Structural flexibility of human alpha-dystroglycan 37
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site 35
Live optical super-resolution microcospy applied to the characterization of maturation, localization and trafficking of defective dystroglycan mutants 34
Structural flexibility of human ?lpha-dystroglycan 34
The enzymatic processing of ?-dystroglycan by MMP-2 is controller by two anchoring sites distinct from the active site 34
Alpha-Dystroglycan is a potential target of matrix metalloproteinase MMP-2 33
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. 33
The effect of an ionic detergent on the natively unfolded beta-dystroglycan ectodomain and on its interaction with alpha-dystroglycan 33
Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain 33
Insights from molecular dynamics simulations: Structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model 32
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 32
A molecular overview of the primary dystroglycanopathies 32
optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants 32
MicroRNA from human peripheral blood leukocytes and cardiovascular diseases 31
Immunological dissection of the human dystroglycan complex 31
?-Dystroglycan hypoglycosylation affects cell migration by influencing ?-dystroglycan membrane clustering and filopodia length: A musticale confocal microscopi analysis 31
Analisi strutturale e funzionale dei domini del distroglicano: ruolo per la stabilità del muscolo e aspetti fisiopatologici 31
Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro 30
Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin. 30
A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics 29
Analysis of alpha-Dystroglycan/LG Domain Binding Modes: Investigating Protein Motifs That Regulate the Affinity of Isolated LG Domains 29
First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle 29
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 28
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor 28
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 27
Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function 27
The Multiple Affinities of alpha-Dystroglycan 27
Dystroglycan is associated to the disulfide isomerase ERp57 27
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 26
An adhesion molecule involved in muscular dystrophies: structural and functional analysis of dystroglycan domains 26
Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo 26
Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan 26
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan. 25
The evolution of the dystroglycan complex, a major mediator of muscle integrity. 25
A Gain-of-Glycosylation Mutation Associated with Myoclonus-Dystonia Syndrome Affects Trafficking and Processing of Mouse epsilon-Sarcoglycan in the Late Secretory Pathway 25
Internal (His)(6)-tagging delivers a fully functional hetero-oligomeric class II chaperonin in high yield 25
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan 25
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Idendification of the Main Cleavage Site 25
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan 24
Structural insights into a protein folding machine 24
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan. 24
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 24
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 24
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 24
Dystroglycan's core protein revival: more on domain organization and function 23
Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino. 23
A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. 23
Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders 23
Cib2 binds integrin alpha 7B beta 1D and is reduced in laminin alpha 2 chain-deficient muscular dystrophy 23
The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation 22
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 22
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex 22
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? 22
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex 22
Mutagenesis of the ±- and ²- dystroglycan interface 22
The dystroglycan complex: From biology to cancer 21
FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies 21
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 21
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 21
±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging 21
Corneal deposit of ciprofloxacin after Laser Sub-Epithelial Keratomileusis (LASEK) procedure. 21
Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor 21
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. 21
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution 21
Insertion of 16 Amino Acids in the BAR Domain of the Oligophrenin 1 Protein Causes Mental Retardation and Cerebellar Hypoplasia in an Italian Family 21
Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression 20
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection 20
Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives 20
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. 20
The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture 20
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 19
The transmembrane collagen gliomedin interacts with perlecan, NrCAM and neurofascin at the nodes of Ranvier 19
Totale 3.313
Categoria #
all - tutte 13.603
article - articoli 8.931
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 1 0 5 2
2024/20252.065 1 9 155 71 480 253 10 72 44 69 499 402
2025/20261.937 127 306 369 469 464 166 36 0 0 0 0 0
Totale 4.010